| ID | Sequence | Length | GC content |
|---|---|---|---|
| ACUCCAUGUGAUGUUUGCUUGGUUGCCUGUUCCCUUUUCUACCUGCAGA… | 1923 nt | 0.5273 | |
| GGGUGAGAGGGCCGGCCUGGACCCGGCGGGCGCACGGCUCCGAGCCCAG… | 2343 nt | 0.5433 | |
| ACUCCAUGUGAUGUUUGCUUGGUUGCCUGUUCCCUUUUCUACCUGCAGA… | 2061 nt | 0.5235 | |
| GGGUGAGAGGGCCGGCCUGGACCCGGCGGGCGCACGGCUCCGAGCCCAG… | 2090 nt | 0.5431 | |
| ACUCCAUGUGAUGUUUGCUUGGUUGCCUGUUCCCUUUUCUACCUGCAGA… | 1952 nt | 0.5241 | |
| ACUCCAUGUGAUGUUUGCUUGGUUGCCUGUUCCCUUUUCUACCUGCAGA… | 1826 nt | 0.5340 | |
| ACUCCAUGUGAUGUUUGCUUGGUUGCCUGUUCCCUUUUCUACCUGCAGA… | 1425 nt | 0.5025 | |
| ACUCCAUGUGAUGUUUGCUUGGUUGCCUGUUCCCUUUUCUACCUGCAGA… | 1760 nt | 0.5142 |
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
A study in humans demonstrated that the TBXAS1 was identified as a top five upregulated long noncoding RNA in traumatic brain injury tissues, with its expression verified by qRT-PCR [Zhang et al. DOI:10.097/WNR.0000000000001756]. In a separate forensic investigation in humans, the TBXAS1 was evaluated as an mRNA candidate for predicting the time-of-day of bloodstain deposition but was removed from the final predictive model due to high correlation with other markers [Gosch et al. DOI:10.1101/2025.02.03.636230].